Company announcement – No. 21 / 2025 Total number of shares and voting rights in Zealand Pharma as of September 30, 2025 Copenhagen, Denmark, September 30, 2025 – Zealand Pharma A/S ("the Company" or “Zealand Pharma”) (Nasdaq: ZEAL) (CVR-no. 20045078), a biotechnology company focused on the discovery and development of innovative peptide-based medicines, today announces, in accordance with section 32 of the Danish Capital Markets Act, the total number of shares and voting rights in the Company at the end of ...

Group 1 - The company Kaldvik AS has resolved to settle a receivable of NOK 43,594,165 related to the acquisition of Mossi ehf. by issuing 1,579,498 new shares [1][2] - The new shares will be issued to Heimstø AS, which is associated with a primary insider of Kaldvik AS [2] - Following the share capital increase, the company's total share capital will amount to NOK 16,826,833.50, divided into 168,268,335 shares, each with a nominal value of NOK 0.10 [3] Group 2 - The company will register the new share capital increase with the Norwegian Register of Business Enterprises and will announce the completion of this registration [3] - This information is subject to the disclosure requirements of Regulation EU 596/2014 (MAR) and the Norwegian Securities Trading Act [4]

Group 1 - The Company, Grigeo Group AB, has announced that it received notifications of transactions conducted by persons discharging managerial responsibilities [1] - These transactions involve the acquisition of shares in the Company, completing the implementation of a resolution from the Annual General Meeting of Shareholders held on April 28, 2025, to increase the Company's share capital and approve revised Articles of Association [2] - Under this resolution, shares have been granted to employees of the Company and its subsidiaries free of charge through the issuance of new shares, which were fully paid from a reserve established for this purpose [3]

Core Points - The Board of EPSO-G has convened an Extraordinary General Meeting to discuss significant investment decisions [1] - EPSO-G plans to invest EUR 18,643,560 in its subsidiary UAB EPSO-G Invest by increasing its authorized capital and shares [2] - The meeting agenda includes the approval of the decision to increase shares in UAB EPSO-G Invest and the essential terms of the share subscription agreement [3] Company Structure - EPSO-G is a holding company with six direct subsidiaries: Amber Grid, Baltpool, Energy Cells, EPSO-G Invest, Litgrid, and Tetas [4] - EPSO-G and its subsidiaries also hold shares in GET Baltic, Baltic RCC OÜ, and TSO Holding AS [4] - The Ministry of Energy of the Republic of Lithuania exercises the rights and obligations of the sole shareholder of EPSO-G [4]

Core Viewpoint - Nordic Fibreboard AS is set to merge with Pärnu Riverside Development OÜ, with Nordic Fibreboard AS as the acquiring company, and the merger will not increase its share capital [1][4]. Group 1: Merger Details - The merger agreement was signed on 30 July 2025, with the balance sheet date for the merger set as 1 June 2025 [1]. - Pärnu Riverside Development OÜ will cease to exist post-merger, and Nordic Fibreboard AS will become its legal successor [4]. - No merger report will be prepared, and the merger agreement does not require auditing [5]. Group 2: Share Capital Increase - The Supervisory Board proposes a conditional increase of Nordic Fibreboard AS's share capital by €400,000, bringing the total conditional share capital to €849,906.1 [6]. - The purpose of the capital increase is to facilitate a public offering of shares and list them on the secondary list of the Nasdaq Tallinn Stock Exchange [6]. - The issue price for the new shares is set at €0.50 per share, with €0.10 as nominal value and €0.40 as premium, reflecting the company's financial challenges [6]. Group 3: Shareholder Meeting - An extraordinary general meeting of shareholders is scheduled for 1 September 2025, with registration starting at 9:45 [2]. - The list of shareholders entitled to participate will be fixed as of 25 August 2025 [3]. - Shareholders holding at least 1/20 of the share capital can demand additional agenda items or submit draft resolutions [15][16].

Core Points - IDEX Biometrics ASA has issued new shares to employees, contractors, and directors, totaling 299,381,600 shares on June 15, 2025 [1] - An additional 5,412,932 shares were issued in lieu of cash board remuneration as approved by the annual general meeting on May 21, 2025 [1] - A small issuance of 69 shares was made to an employee to facilitate a 100-to-1 share consolidation resolved on April 11, 2025 [1] Company Overview - IDEX Biometrics ASA is a global leader in fingerprint biometrics, providing authentication solutions for payments, access control, and digital identity [3] - The company's biometric solutions are built on patented sensor technologies, integrated circuit designs, and software, targeting card-based applications for payments and digital authentication [3] - IDEX partners with leading card manufacturers and technology companies to bring its biometric solutions to market [3] Share Capital Information - Following the recent share capital increases, the company's total share capital is NOK 47,364,256.00, divided into 4,736,425,600 shares, each with a nominal value of NOK 0.01 [2]

Core Points - The Supervisory Board of AS Harju Elekter Group has decided to increase the company's share capital by 17,010 euros through the issuance of new ordinary shares [1][4] - The increase is intended to facilitate the share option program for management board members and key personnel, as approved in the general meeting on April 29, 2021 [1][4] Share Issuance Details - A total of 27,000 new ordinary shares will be issued at a price of 4.50 euros per share, with a book value of 0.63 euros and a share premium of 3.87 euros [4] - The total subscription amount for the shares is 121,500 euros, with 4 current and former employees participating in the share issue [2][4] - 57,500 shares remain unsubscribed and will be cancelled [2][4] Capital Structure Changes - Following the capital increase, Harju Elekter's total share capital will rise from 11,654,225.10 euros to 11,671,235.10 euros, resulting in a total of 18,525,770 ordinary shares without nominal value [4] - The new shares will be listed on Nasdaq Tallinn after being included in the Estonian Central Securities Depository [4] Subscription Rights - The pre-emptive right to subscribe for new shares is limited to management board members and key personnel involved in the option program, excluding other shareholders [4] - The deadline for exercising subscription rights was set for June 25, 2025, with timely submissions from option beneficiaries [4]

Core Viewpoint - IDEX Biometrics ASA's board has approved the issuance of 299,381,600 new shares at NOK 0.01 per share to incentivize personnel in implementing the amended business plan and commercializing the company's products [1][2]. Group 1: Share Issuance Details - The share issuance is part of a Personnel Placement authorized by an extraordinary general meeting held on 11 April 2025, which also approved terms for debt conversion [2]. - The shares will be restricted for 18 months post-issuance, with 1/3 released after 6 months and another 1/3 after 12 months [3]. - The company retains the right to repurchase restricted shares if a holder resigns or is terminated [3]. Group 2: Compliance and Impact - The board has ensured that the Personnel Placement complies with equal treatment obligations under relevant Norwegian laws and Oslo Stock Exchange rules [4]. - The number of new shares represents approximately 6.7% of the total outstanding shares, with a limited dilutive effect on existing shareholders [4]. - The subscription price of NOK 0.01 represents a 78% discount to the closing price on 13 June 2025, with potential variations in discount due to the lock-up period and share volatility [4]. Group 3: Company Overview - IDEX Biometrics ASA is a global leader in fingerprint biometrics, providing authentication solutions for payments, access control, and digital identity [6]. - The company's biometric solutions are built on patented technologies and target card-based applications for payments and digital authentication [6].

Group 1 - Heimar hf. has announced the acquisition of all shares in Gróska ehf. and Gróðurhúsið ehf. [1] - The purchase price for the acquisition will be settled through the issuance of 258 million new shares in Heimar [2] - Following the issuance, Heimar's share capital will increase from ISK 1,763,901,137 to ISK 2,021,901,137 [2] Group 2 - The new shares will be issued by Nasdaq CSD and will be applied for listing on the Main Market of Nasdaq Iceland [3] - The issuance is based on an authorization granted at the Company's Annual General Meeting held on 11 March [2]

Core Viewpoint - IDEX Biometrics ASA has successfully completed a Subsequent Offering of up to 600,000,000 new shares, which was 8 times oversubscribed, raising gross proceeds of NOK 6 million [3]. Company Information - IDEX Biometrics ASA is a global technology leader in fingerprint biometrics, providing authentication solutions for payments, access control, and digital identity [13]. - The company's biometric solutions are built on patented sensor technologies and target card-based applications for payments and digital authentication [13]. Offering Details - The Subscription Period for the Subsequent Offering commenced on 22 May 2025 and expired on 5 June 2025 [2]. - The total number of Offer Shares allocated was 600,000,000 at a subscription price of NOK 0.01 per share [3]. - The share capital increase related to the Subsequent Offering is expected to be registered in the Norwegian Register of Business Enterprises on or about 13 June 2025, resulting in a total share capital of NOK 44,316,309.99 [5]. Shareholder Information - Investors allocated Offer Shares can access their allocation information through VPS on or about 6 June 2025, with payment due on 11 June 2025 [4]. - The Offer Shares will rank equally with the company's existing shares [6].